Safety and efficacy of vitamin K antagonists versus rivaroxaban in hemodialysis patients with atrial fibrillation: a multicenter randomized controlled trial - De Vriese, AS; Caluwé, R; Van Der Meersch, H (J Am Soc Nephrol, 2021)